Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Exchange Rate Effect: 2020-2022

Historic Exchange Rate Effect for Xeris Biopharma Holdings (XERS) over the last 1 years, with Sep 2022 value amounting to $1,000.

  • Xeris Biopharma Holdings' Exchange Rate Effect rose 150.00% to $1,000 in Q3 2022 from the same period last year, while for Sep 2022 it was -$4,000, marking a year-over-year change of. This contributed to the annual value of -$3,000 for FY2021, which is 86.36% up from last year.
  • According to the latest figures from Q3 2022, Xeris Biopharma Holdings' Exchange Rate Effect is $1,000, which was up 200.00% from -$1,000 recorded in Q1 2022.
  • Xeris Biopharma Holdings' Exchange Rate Effect's 5-year high stood at $6,000 during Q4 2020, with a 5-year trough of -$2,000 in Q3 2021.
  • Its 3-year average for Exchange Rate Effect is $500, with a median of $0 in 2021.
  • In the last 5 years, Xeris Biopharma Holdings' Exchange Rate Effect plummeted by 133.33% in 2021 and then skyrocketed by 150.00% in 2022.
  • Quarterly analysis of 3 years shows Xeris Biopharma Holdings' Exchange Rate Effect stood at $6,000 in 2020, then crashed by 133.33% to -$2,000 in 2021, then skyrocketed by 150.00% to $1,000 in 2022.
  • Its Exchange Rate Effect stands at $1,000 for Q3 2022, versus -$1,000 for Q1 2022 and -$2,000 for Q4 2021.